Physician profile
Wilber Wei-Poh Su
NPI 1689618084
$1,145,360.20
in general payments reported to CMS, 2019-2025
46 companies · $277K in 2025
The $277K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213K · 2020: $147K · 2021: $98K · 2022: $76K · 2023: $154K · 2024: $181K · 2025: $277K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $280K · Consulting Fee: $235K · Travel and Lodging: $69K · Food and Beverage: $22K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $279,838.00 |
| Consulting Fee | $235,251.64 |
| Travel and Lodging | $68,753.31 |
| Food and Beverage | $21,898.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $435,771.82 | 2019-2025 | Farapulse, General - Ep, General - Therapies |
| Medtronic Vascular, INC. | $294,921.92 | 2019-2020 | |
| Synaptic Medical Corporation | $207,243.74 | 2023-2025 | |
| Medtronic, INC. | $138,895.81 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Na, Affera Mapping System |
| Abbott Laboratories | $13,972.39 | 2019-2025 | Ensite Precision, Ensite, Gallant |
| Stryker Corporation | $13,622.17 | 2019-2021 | |
| Atricure, INC. | $8,169.78 | 2019-2024 | |
| Cortex, INC. | $6,172.22 | 2024 | |
| Baylis Medical Company INC | $4,167.38 | 2019-2021 | |
| Merit Medical Systems INC | $4,050.00 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $3,827.16 | 2020-2025 | Optimizer |
| Sanofi-Aventis U.S. LLC | $3,399.09 | 2020-2023 | |
| Altathera Pharmaceuticals LLC | $2,114.27 | 2025 | Sotalol Hydrochloride |
| Acutus Medical, INC. | $1,989.00 | 2019-2021 | |
| Biosense Webster, INC. | $1,736.50 | 2019-2025 | Carto 3 |
Show all 45 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilber Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.